Literature DB >> 20478252

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Alexander Roesch1, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, Susan E Zabierowski, Patricia A Brafford, Adina Vultur, Devraj Basu, Phyllis Gimotty, Thomas Vogt, Meenhard Herlyn.   

Abstract

Melanomas are highly heterogeneous tumors, but the biological significance of their different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-H1) as a biomarker, we have characterized a small subpopulation of slow-cycling melanoma cells that cycle with doubling times of >4 weeks within the rapidly proliferating main population. Isolated JARID1B-positive melanoma cells give rise to a highly proliferative progeny. Knockdown of JARID1B leads to an initial acceleration of tumor growth followed by exhaustion which suggests that the JARID1B-positive subpopulation is essential for continuous tumor growth. Expression of JARID1B is dynamically regulated and does not follow a hierarchical cancer stem cell model because JARID1B-negative cells can become positive and even single melanoma cells irrespective of selection are tumorigenic. These results suggest a new understanding of melanoma heterogeneity with tumor maintenance as a dynamic process mediated by a temporarily distinct subpopulation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478252      PMCID: PMC2882693          DOI: 10.1016/j.cell.2010.04.020

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer.

Authors:  T Vogt; M Kroiss; M McClelland; C Gruss; B Becker; A K Bosserhoff; G Rumpler; T Bogenrieder; M Landthaler; W Stolz
Journal:  Lab Invest       Date:  1999-12       Impact factor: 5.662

2.  Melanoma cell lines from different stages of progression and their biological and molecular analyses.

Authors:  K Satyamoorthy; E DeJesus; A J Linnenbach; B Kraj; D L Kornreich; S Rendle; D E Elder; M Herlyn
Journal:  Melanoma Res       Date:  1997-08       Impact factor: 3.599

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.

Authors:  Alexander Roesch; Bernd Becker; Stefanie Meyer; Peter Wild; Christian Hafner; Michael Landthaler; Thomas Vogt
Journal:  Mod Pathol       Date:  2005-09       Impact factor: 7.842

6.  A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer.

Authors:  P J Lu; K Sundquist; D Baeckstrom; R Poulsom; A Hanby; S Meier-Ewert; T Jones; M Mitchell; P Pitha-Rowe; P Freemont; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

7.  A tumorigenic subpopulation with stem cell properties in melanomas.

Authors:  Dong Fang; Thiennga K Nguyen; Kim Leishear; Rena Finko; Angela N Kulp; Susan Hotz; Patricia A Van Belle; Xiaowei Xu; David E Elder; Meenhard Herlyn
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

8.  Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.

Authors:  Keith Tan; Anthony L Shaw; Bente Madsen; Kirsten Jensen; Joyce Taylor-Papadimitriou; Paul S Freemont
Journal:  J Biol Chem       Date:  2003-03-25       Impact factor: 5.157

9.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  520 in total

Review 1.  Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.

Authors:  Inna V Fedorenko; Kim H T Paraiso; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2011-05-25       Impact factor: 5.858

2.  Evidence for label-retaining tumour-initiating cells in human glioblastoma.

Authors:  Loic P Deleyrolle; Angus Harding; Kathleen Cato; Florian A Siebzehnrubl; Maryam Rahman; Hassan Azari; Sarah Olson; Brian Gabrielli; Geoffrey Osborne; Angelo Vescovi; Brent A Reynolds
Journal:  Brain       Date:  2011-04-22       Impact factor: 13.501

3.  Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

Authors:  Kaijie He; Tong Xu; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

Review 4.  A brief history of melanoma: from mummies to mutations.

Authors:  Vito W Rebecca; Vernon K Sondak; Keiran S M Smalley
Journal:  Melanoma Res       Date:  2012-04       Impact factor: 3.599

Review 5.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

6.  Cancer stem cells: Invitation to a second round.

Authors:  Peter Dirks
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

7.  Don't let sleeping cells lie.

Authors:  Teresa Villanueva
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

8.  Dynamic and transient cancer stem cells nurture melanoma.

Authors:  Robert Weinberg; David E Fisher; Jeremy Rich
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

9.  The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Authors:  Rebeca A Frum; Yanping Zhang
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

10.  Memory Sequencing Reveals Heritable Single-Cell Gene Expression Programs Associated with Distinct Cellular Behaviors.

Authors:  Sydney M Shaffer; Benjamin L Emert; Raúl A Reyes Hueros; Christopher Cote; Guillaume Harmange; Dylan L Schaff; Ann E Sizemore; Rohit Gupte; Eduardo Torre; Abhyudai Singh; Danielle S Bassett; Arjun Raj
Journal:  Cell       Date:  2020-07-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.